Member Exclusive

New drug target identified for glioblastoma treatment

Researchers at the National Institute for Basic Biology (Okazaki, Japan) demonstrated that the enzymatic activity of R5 receptor-type protein tyrosine phosphatases is a requisite for the maintenance of stem cell properties and tumorigenicity in glioblastoma cells and could be a promising drug target for treatment.

Go to the profile of Peter Brown
Aug 02, 2017

Please sign in or register for FREE to view this content

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet. Start the conversation...